# Cercare Medical A/S

- Location (FDA's records): Aarhus C, DK
- FDA decisions: 4 (2023–2026): 4 510(k) clearances
- Product codes: LLZ (3), QIH (1)
- 510(k) review time since 2016: median 160 days, against 131 for FDA's reviews in the same codes and years (0 of 4 faster)
- Predicates its devices cite: 4 (2 its own); citations of its devices by later devices: 2 (2 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Cercare Medical Aps: 1 (https://510kreport.com/company/cercare-medical)
- Neosoma, Inc.: 1 (https://510kreport.com/company/neosoma)

## Its most-cited devices
- K230016: Cercare Medical Neurosuite (2023), cited by 1
- K241989: Cercare Medical Neurosuite (CMN) Capillary Function with Virtual Expert (2024), cited by 1

## Recent decisions
- K260316: CMN Capillary Function with Oncology Virtual Expert (Jun 22, 2026)
- K253831: CMN Capillary Function with Virtual Expert for MRI, CT and CBCT (May 18, 2026)
- K241989: Cercare Medical Neurosuite (CMN) Capillary Function with Virtual Expert (Dec 6, 2024)
- K230016: Cercare Medical Neurosuite (Jul 14, 2023)

Source page: https://510kreport.com/company/cercare-medical-a-s